The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
...and at an attractive price.
cash returning. FOMO
Ah, nice to see buying @ 35.50p again :)
Anyone surprised?
apologies typo. 33.25p
15min chart juicy.
Was 32.25p the bottom. Famous last words :)
Buying @ 33.90 now.
I suspect there's lots of money on the sidelines waiting to buy in here.
Waiting for bottom in this instance could prove costly. Buy on belief when everyone else is fearful.
Added further:
65000
65001
37681
Will look again if drops below 32p.
Thks for the opportunity :)
POOLBEG PHARMA LIMITED
Company number 13356328
Incorporated April 2021
I must be behind the curve. Missed this one.
Challenge study boom
Friel said the day for challenge studies has arrived as demand spiked in the wake of the pandemic. In previous years, hVIVO usually completed 2-3 challenge studies per year. However, that has increased to potentially 10 this year, with as many as 20 studies planned for next year.
Oasis2000
Spot on!
Exactly my view.
Buyers @ 37.25p
"I see 50% chance of this falling to 35p still"
Probably the most redundant and meaningless comment i've read/heard this year.
Thanks for the laugh.
Blue close.
SP didn't care to stay around 37.3 today. Bodes well.
Justed added 196249 via several trades between 37.325 and 37.90
Paul Johnson, Chief Executive Officer of Power Metal Resources commented:
"Today's news marks a key point in the development of RRAL with the grant of the Evergreen tenement which is one of the larger licence applications and sits in an area of particular interest as demonstrated by increasing investment by peer companies in project acquisition and exploration.
Grant of the two licences moves the IPO process front and centre. We believe that the core interests of RRAL forming the basis for an IPO on the Canadian capital markets represents one of the most comprehensive investment opportunities in the Victoria Goldfields for Canadian and international investors.
RRAL are therefore moving forward at pace with both project exploration and corporate listing developments.